| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |